| The right message served to the right patient sounds great, but even that pairing loses its power if it's served in the ...

To what extent will health clinics go to keep selling in-demand weight-loss drugs now that the FDA has outlawed cheaper ...

Massive cuts at the FDA have hit staff tied to drug reviews and user fees, putting future approvals in jeopardy, according to ...

Funnyman Kenan Thompson is opening up about the not-so-funny experience of living with gastroesophageal reflux disease (GERD) ...

With concerns mounting and speculation swirling, the particulars of President Donald Trump’s much-touted “Liberation Day” ...

But at the same time, industry leaders are bracing for the news that they think is inevitable given Trump’s declaration in ...

It's not yet been a week since Marty Makary, M.D., was confirmed to lead the FDA as its commissioner. | Peter Marks, M.D., Ph ...

As the FDA wavers from cuts, changes and departures under the second Trump administration, another vital figure of the agency ...

After a Houston judge denied Johnson & Johnson’s third attempt to resolve approximately 90,000 talcum powder lawsuits through ...

With a label expansion for Uplizna pushing the drug into an untouched rare disease market, Amgen is getting its money’s worth ...

As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...

In response to a request from the European Medicines Agency (EMA) following the death of a 16-year-old patient in the U.S., ...